Nomeco
Christian Frandsen currently serves as Group CFO at Nomeco, a position held since February 2025. Previously, Christian was Group CFO at Sever Pharma Solutions from May 2020 to January 2025, contributing to its reputation as a global contract development and manufacturing organization specializing in polymer-based dosage forms. Prior to that, Christian held several significant roles at Novo Nordisk, including CFO at Novo Nordisk Pharmatech A/S, and CFO - Director of Finance and Operations at Novo Nordisk Mexico S.A. de C.V. and Novo Nordisk Scandinavia AB. Christian’s career began as a Consultant at the Confederation of Danish Industries, with foundational education in law and business from esteemed institutions such as the University of Copenhagen and Copenhagen Business School, alongside an E*MBA from IMD.
This person is not in any teams
This person is not in any offices
Nomeco
Nomeco is Denmark's largest pharmaceutical wholesaler and an international competency center for the pharmaceutical industry. At Nomeco we specialize in healthcare logistics. We ensure that the Danish population always has timely access to pharmaceuticals. This goal is realized through a value adding partnership with pharmacies and the pharmaceutical industry – a partnership based on security, confidence and a high level of ethics. Nomeco is undergoing constant development in close contact with the market and authorities. This development rests on a solid base of knowledge and values. Nomeco is a Danish company deeply rooted in the pharmaceutical industry while at the same time being part of an international organization.